Markets:

Overview

News

Currencies

International

Treasuries

Eli Lilly (NY:LLY)

1,103.40 +1.33 (+0.12%)

Streaming Delayed Price Updated: 12:46 PM EDT, Jun 23, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Eli Lilly vs Viking Therapeutics: Which GLP-1 Stock Is the Better Buy? ↗

Today 10:34 EDT

The GLP-1 drug market is massive and still growing fast. Investing in a promising growth stock in the space could lead to significant returns.

Via The Motley Fool

3 Monster Stocks to Hold for the Next 10 Years ↗

Today 6:25 EDT

These healthcare stocks may be the building blocks of a winning portfolio.

Via The Motley Fool

Topics Intellectual Property

2 Underrated Weight Loss Stocks to Buy and Hold ↗

Today 3:05 EDT

They look well-positioned to grab a slice of the fast-growing anti-obesity market.

Via The Motley Fool

Eli Lilly & Co. (NYSE:LLY): A High-Growth Champion Aligned with Navellier's Proven Strategy ↗

June 22, 2026

Via Chartmill

Eli Lilly & Co (NYSE:LLY): A Dividend Growth Gem with Strong Fundamentals ↗

June 19, 2026

Via Chartmill

Eli Lilly & Co. (NYSE:LLY): High Growth Momentum Meets Strong Technical Breakout Setup ↗

June 16, 2026

Via Chartmill

Branded Pharmaceuticals Stocks Q1 Teardown: Supernus Pharmaceuticals (NASDAQ:SUPN) Vs The Rest

June 22, 2026

As the Q1 earnings season comes to a close, it’s time to take stock of this quarter’s best and worst performers in the branded pharmaceuticals industry, incl...

Via StockStory

Topics Artificial Intelligence Intellectual Property

Why This Mid-Cap Biotech Could Be the Dark-Horse Threat to Eli Lilly and Novo Nordisk ↗

June 22, 2026

Viking Therapeutics aspires to take market share from both Eli Lilly and Novo Nordisk, and it might succeed.

Via The Motley Fool

WSTPR Catalyst Watch: Abu Dhabi Regulatory Clearance Adds Momentum to NeOnc's Global Neuro-Oncology Strategy

June 22, 2026

Houston, Texas--(Newsfile Corp. - June 22, 2026) - NeOnc Technologies Holdings (NASDAQ: NTHI) recently achieved what many biotechnology companies spend...

Via Newsfile

1 Vanguard Index Fund Could Turn $450 Per Month Into a $905,200 Portfolio That Pays $16,400 in Annual Dividend Income ↗

June 22, 2026

Young adults with median earnings can build sizable portfolios that pay a hefty amount of passive income by retirement.

Via The Motley Fool

Topics ETFs Retirement

13 Stocks Are Members of the $1 Trillion Club. Here's the Best Pick to Buy Right Now. ↗

June 22, 2026

Want to really go big? One megacap stock offers an especially attractive risk-reward proposition.

Via The Motley Fool

Topics Artificial Intelligence

Pfizer's Dividend Yield is 10X Bigger Than Eli Lilly's. Does That Make It the Better Stock for Income Investors? ↗

June 20, 2026

Pfizer is out of favor right now, and for good reason, but dividend investors may want to take the risk just the same.

Via The Motley Fool

Topics Intellectual Property

Novo Nordisk's Wegovy Pill Just Hit 3 Million Prescriptions. Is Wall Street Missing Something With This Beaten-Down Stock? ↗

June 20, 2026

Novo Nordisk has been telling investors that volume will eventually offset price cuts, and early results suggest investors should listen.

Via The Motley Fool

Lilly's 7 Acquisitions in 3 Months: Which Will Be the Biggest Game-Changer for the Pharma Giant? ↗

June 20, 2026

Eli Lilly's spate of acquisitions is building out multiple areas of its pipeline at once.

Via The Motley Fool

3 Penny Stocks Under $5 Backed by Real Revenue Growth ↗

June 20, 2026

These three penny stocks under $5 generate real revenue and have catalysts that analysts believe could drive significant upside

Via MarketBeat

3 Non-Pharma Firms That Could Benefit From the GLP-1 Trend ↗

June 20, 2026

With GLP-1 usage continuing to rise, a group of unlikely beneficiaries is emerging; stocks in the broader health care sector and even in retail could stand out.

Via MarketBeat

Topics ETFs

3 Reasons to Buy Eli Lilly Stock ↗

June 20, 2026

Despite several setbacks over the past year, the drugmaker marches on.

Via The Motley Fool

Vertex Has a Head Start in Non-Opioid Pain. Eli Lilly Just Spent Billions to Catch Up. Here's What That Means for Both Stocks. ↗

June 20, 2026

These companies don't typically compete directly with one another, but that might change soon.

Via The Motley Fool

Here’s How Much You Would Have Made Owning Eli Lilly Stock In The Last 15 Years ↗

June 19, 2026

Eli Lilly (NYSE:LLY) has outperformed the market over the past 15 years by 12.92% on an annualized basis producing an average annual ...

Via Benzinga

The Next Wave of Medical AI Could Mint More Millionaires Than the First -- Here Are the Stocks to Own ↗

June 19, 2026

AI's next winners in healthcare could be companies like Eli Lilly and Twist Bioscience.

Via The Motley Fool

Topics Artificial Intelligence

Market-Weighted Healthcare or Active Manager Selection? IYH vs. PINK ↗

June 18, 2026

The iShares U.S. Healthcare ETF (IYH) tracks a broad healthcare index, while the Simplify Health Care ETF (PINK) gives an active manager more room to choose. That difference matters for investors...

Via The Motley Fool

Topics ETFs

Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought ↗

June 18, 2026

After a few days of purging, the Ark Invest growth investor is buying stocks again.

Via The Motley Fool

3 Stocks Doing the Heavy Lifting in Healthcare’s Rebound ↗

June 18, 2026

Led by Eli Lilly’s GLP-1 success, Humana’s expanding margins, and DexCom’s medtech growth, the healthcare sector is staging a major market rebound.

Via MarketBeat

Vanguard (VHT) vs VanEck (PPH): Which Healthcare ETF Is the Better Buy? ↗

June 18, 2026

Broader diversification or higher yield? Explore how these two healthcare ETFs stack up for different investor goals.

Via The Motley Fool

Topics ETFs

Is iShares Pharma ETF (IHE) or SPDR's Biotech ETF (XBI) the Better Long-Term Buy for Investors? ↗

June 17, 2026

Compare risk profiles, sector concentration, and income potential as these two healthcare ETFs take different approaches to growth and stability.

Via The Motley Fool

Topics ETFs

3 Underrated Dividend Stocks That Could Generate Reliable Cash Flow for Your Portfolio for Decades ↗

June 17, 2026

These stocks may not be your first choices when looking for dividends, but they have been income-generating machines for years.

Via The Motley Fool

Eli Lilly vs. Novo Nordisk: Better Obesity Drug Stock? ↗

June 16, 2026

These two healthcare leaders have a long history of competing against one another.

Via The Motley Fool

Health Care ETFs: XLV Delivers Low Fees and Solid Returns ↗

June 16, 2026

Explore how portfolio concentration and stock count set these healthcare ETFs apart, impacting risk and diversification for investors seeking sector exposure.

Via The Motley Fool

Topics ETFs

FHLC vs. IYH: Which Healthcare ETF Is the Better Buy in 2026? ↗

June 16, 2026

Portfolio size and stock selection set these healthcare ETFs apart and help shape their risk and return profiles.

Via The Motley Fool

Topics ETFs

3 Under-the-Radar Stocks to Buy and Hold for a Decade ↗

June 16, 2026

All three could become highly prominent biotech companies within 10 years.

Via The Motley Fool

< Previous 1 2 3 4 5 6 7 8 9

...

99 100 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.